Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,829,852
  • Shares Outstanding, K 94,566
  • Annual Sales, $ 276,740 K
  • Annual Income, $ 2,640 K
  • 60-Month Beta 0.94
  • Price/Sales 6.41
  • Price/Cash Flow 58.00
  • Price/Book 5.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.02
  • Number of Estimates 3
  • High Estimate 0.03
  • Low Estimate 0.01
  • Prior Year 0.02
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.00 +7.72%
on 03/07/19
20.31 -4.53%
on 03/18/19
+0.54 (+2.86%)
since 02/26/19
3-Month
11.73 +65.30%
on 12/27/18
20.31 -4.53%
on 03/18/19
+7.49 (+62.94%)
since 12/26/18
52-Week
7.71 +151.49%
on 04/02/18
20.31 -4.53%
on 03/18/19
+11.17 (+135.89%)
since 03/26/18

Most Recent Stories

More News
Fluidigm Corp is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (FLDM , NEO , PRAH , TMO , PKI )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

NEO : 19.39 (+0.21%)
PRAH : 108.02 (+1.68%)
FLDM : 13.49 (-3.02%)
Relatively Good Performance Detected in Shares of Bruker Corp in the Life Sciences Tools & Services Industry (BRKR , NEO , WAT , TMO , FLDM )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

BRKR : 38.30 (+0.47%)
NEO : 19.39 (+0.21%)
WAT : 248.77 (+1.02%)
Neogenomics Inc Shares Up 52.7% Since SmarTrend's Buy Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 2 months, Neogenomics Inc has returned 52.71% as of today's recent price of $19.89.

NEO : 19.39 (+0.21%)
Relatively Good Performance Detected in Shares of Fluidigm Corp in the Life Sciences Tools & Services Industry (FLDM , NEO , TMO , WAT , PRAH )

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks...

TMO : 271.44 (+0.98%)
NEO : 19.39 (+0.21%)
FLDM : 13.49 (-3.02%)
Neogenomics Inc Has Returned 44.0% Since SmarTrend Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 2 months, Neogenomics Inc has returned 44.03% as of today's recent price of $18.76.

NEO : 19.39 (+0.21%)
Nanostring Techn has the Best Relative Performance in the Life Sciences Tools & Services Industry (NSTG , NEO , CRL , PACB , A )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

NEO : 19.39 (+0.21%)
CRL : 143.20 (+0.60%)
NSTG : 23.72 (+1.63%)
NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference

FT MYERS, FL / ACCESSWIRE / March 7, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that Sharon Virag, Chief Financial Officer, and...

NEO : 19.39 (+0.21%)
50.5% Return Seen to Date on SmarTrend Neogenomics Inc Call (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 2 months, Neogenomics Inc has returned 50.48% as of today's recent price of $19.60.

NEO : 19.39 (+0.21%)
Neogenomics Inc Shares Up 42.2% Since SmarTrend's Buy Recommendation (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on January 8th, 2019 at $13.03. In approximately 1 month, Neogenomics Inc has returned 42.19% as of today's recent price of $18.52.

NEO : 19.39 (+0.21%)
NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter and full year 2018.

NEO : 19.39 (+0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade NEO with:

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

2nd Resistance Point 19.96
1st Resistance Point 19.67
Last Price 19.39
1st Support Level 19.21
2nd Support Level 19.04

See More

52-Week High 20.31
Last Price 19.39
Fibonacci 61.8% 15.50
Fibonacci 50% 14.01
Fibonacci 38.2% 12.52
52-Week Low 7.71

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar